New vaccine for hepatitis C virus

July 28, 2011

Murdoch University researchers have begun a study to develop a new and innovative vaccine for the hepatitis C virus (HCV).

HCV is spread through blood-to-blood contact and causes liver inflammation and . It affects about 284,000 and 212,000 are living with chronic HCV.

The research in collaboration with Oxford University and funded by the McCusker Foundation, is using a new approach to develop the vaccine, which aims to protect against the majority of circulating HCV strains.

Researcher Michaela Lucas said: “Previous attempts to create a vaccine have been limited because like HIV, escapes our immune system by rapid change of its genome and shape.

“Our project is using genetics to identify these escape patterns so we can create vaccines that take this ability of the virus to change into account. That should mean a higher chance of success.”

Dr. Lucas said if successful, the vaccine could halt the infection cycle by protecting people at risk from initial infection and re-infection.

virus infection is a major global health problem and despite public health efforts in Australia to prevent HCV infection, it has become the most common blood–borne infection,” she said.

“There is currently no vaccine for the prevention of HCV and previous HCV infection does generally not protect from re-infection. Furthermore, available treatment is not accessible to all, is expensive and can have life-threatening complications.

“Even if treatment and newer treatment strategies are successful and eradicate the virus within an individual, it will not prevent re-infection, which is common in high-risk exposure groups.  A vaccine against HCV would provide a mechanism to stop the continuation of the infection cycle.”

Related Stories

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.